Show simple item record

dc.contributor.authorWalemba, Elvin M.en
dc.date.accessioned2016-12-19T11:30:30Z
dc.date.available2016-12-19T11:30:30Z
dc.date.issued2002-09
dc.identifier.citationWalemba, E. (2002) 'Expression of ornithine decarboxylase enzyme in central nervous system tissue in experimental allergic encephalomyelitis (EAE) in the Lewis rat'. Masters by Research thesis. University of Luton.en
dc.identifier.urihttp://hdl.handle.net/10547/621894
dc.description.abstractOrnithine decarboxylase (ODC) is the primary and rate-limiting enzyme in the natural synthesis of polyamines putrescine, spermidine and spermine, which have been implicated in the breakdown of the blood-brain barrier (BBB), the initial event in the pathogenesis of experimental allergic encephalomyelitis (EAE) and multiple sclerosis (MS). This thesis INOUid like to suggest that there is increased expression of ODC during heightened disease expression in EAE, and therefore that ODC is involved in the development of EAE and MS through the polyamine synthetic pathway. To assess the levels of ODC enzyme in central nervous system (CNS) tissue, which included cerebellum, cervical spinal cord and medulla, the tissue was first homogenised and the protein concentration of the resulting sample determined. This required the establishment of an appropriate protein estimation mP.thod i.e. a suitable protein assay. Much time and experimentation was spent on achieving this because of the effect of interfering substances on the assays used. Assessment of the levels of ODC in a model of EAE using normal tissue, CFA treated tissue (control), day-13 post inoculation (PI) (height of disease) and day-21 PI (early recovery stage) was carried out by Western blotting. The studies show that there is increased expression of ODC at the height of disease i.e. day-13 PI in cerebellum and medulla pons tissue but not cervical spinal cord tissue.
dc.language.isoenen
dc.publisherUniversity of Bedfordshireen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectornithine decarboxylaseen
dc.subjectODCen
dc.subjectblood-brain barrieren
dc.subjectexperimental allergic encephalomyelitisen
dc.subjectB132 Pathobiologyen
dc.titleExpression of ornithine decarboxylase enzyme in central nervous system tissue in experimental allergic encephalomyelitis (EAE) in the Lewis raten
dc.typeThesis or dissertationen
refterms.dateFOA2020-05-10T10:55:56Z
html.description.abstractOrnithine decarboxylase (ODC) is the primary and rate-limiting enzyme in the natural synthesis of polyamines putrescine, spermidine and spermine, which have been implicated in the breakdown of the blood-brain barrier (BBB), the initial event in the pathogenesis of experimental allergic encephalomyelitis (EAE) and multiple sclerosis (MS). This thesis INOUid like to suggest that there is increased expression of ODC during heightened disease expression in EAE, and therefore that ODC is involved in the development of EAE and MS through the polyamine synthetic pathway. To assess the levels of ODC enzyme in central nervous system (CNS) tissue, which included cerebellum, cervical spinal cord and medulla, the tissue was first homogenised and the protein concentration of the resulting sample determined. This required the establishment of an appropriate protein estimation mP.thod i.e. a suitable protein assay. Much time and experimentation was spent on achieving this because of the effect of interfering substances on the assays used. Assessment of the levels of ODC in a model of EAE using normal tissue, CFA treated tissue (control), day-13 post inoculation (PI) (height of disease) and day-21 PI (early recovery stage) was carried out by Western blotting. The studies show that there is increased expression of ODC at the height of disease i.e. day-13 PI in cerebellum and medulla pons tissue but not cervical spinal cord tissue.


Files in this item

Thumbnail
Name:
E.M. Walemba PhD 1.pdf
Size:
30.47Mb
Format:
PDF
Description:
Thesis

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by-nc-nd/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-nd/4.0/